MedDx Capital Advisors

Our Work

MedDx’s PRINCIPALS HAVE COMPLETED IN EXCESS OF $1.5 BILLION OF INVESTMENT BANKING TRANSACTIONS AND ADVISORY ENGAGEMENTS FOR SOME OF INDUSTRY’S LEADING COMPANIES.

REPRESENTATIVE ENGAGEMENTS & TRANSACTIONS

DATECLIENTTRANSACTION ROLE
2022Precision oncologyUSAFinancing
2021Tools SoftwareUSABuyside
2021Precision oncologyUSAFinancing
2020ToolsUSABuyside
2020Precision oncologyUSAStrategic Advisory
2020Genomic testingUSABuyside
2020Healthcare ITUSASellside
2020Genomics dataUSAStrategic Advisory
2019Labratory equipmentUSASellside
2019Precision oncologyUSAStrategic Advisory
2018POC IVDUSAVenture Debt
2018Precision oncology testingUSAStrategic Advisory
2017Near-patient IVD companyUSAStrategic Advisory
2017IVD companyChinaStrategic Advisory
2017Fertility LDT company USAStrategic Advisory
2016Oncology IVD company USAStrategic Advisory
2016Oncology LDT company USAStrategic Advisory
2015Acute Care IVD company USAStrategic Advisory
2015Oncology LDT company USAStrategic Advisory
2014Oncology LDT company IsraelStrategic Advisory
2014Diabetes IVD company USAPrivate Placement
2014RUO tools company USAStrategic Advisory
2014Oncology LDT/IVD USAStrategic Advisory
2012Oncology LDT company USAStrategic Advisory
2012Pharmacogenomics lab USABuyside Advisory
2011Genetic testing lab USAStrategic Advisory
2009IVD platform company USAStrategic Advisory
2009Healthcare services USAPublic Offering
2009Specialty pharma company USAStrategic Advisory
2009Medical device company USASellside
2008IVD platform company USAPublic Offering
2007Government outsourcing USAPublic Offering
2007Healthcare IT company USASellside
2006Healthcare IT company USABuyside
2006Government outsourcing USAPublic Offering
2005Nutritional products company USAPublic Offering
2004Womens' health company USAPublic Offering

HOW CAN WE HELP?